NRC National Research Corp
Price (delayed)
$21.4
Market cap
$510.84M
P/E Ratio
17.69
Dividend/share
$1.48
EPS
$1.21
Enterprise value
$552.58M
NRC Health is the leading provider of in-depth customer insights in healthcare.
Highlights
The stock's price to earnings (P/E) is 46% less than its 5-year quarterly average of 32.8 and 41% less than its last 4 quarters average of 30.0
National Research's equity has decreased by 48% YoY but it has increased by 9% QoQ
National Research's debt has surged by 111% YoY
The quick ratio has dropped by 77% year-on-year and by 12% since the previous quarter
Key stats
What are the main financial stats of NRC
Market
Valuations
Earnings
Shares outstanding
23.87M
Market cap
$510.84M
Enterprise value
$552.58M
Price to earnings (P/E)
17.69
Price to book (P/B)
12.71
Price to sales (P/S)
3.49
EV/EBIT
13.95
EV/EBITDA
12.13
EV/Sales
3.78
Revenue
$146.28M
EBIT
$39.61M
EBITDA
$45.56M
Free cash flow
$22.7M
Per share
Balance sheet
Liquidity
EPS
$1.21
Free cash flow per share
$0.95
Book value per share
$1.68
Revenue per share
$6.13
TBVPS
$2.35
Total assets
$119.1M
Total liabilities
$78.9M
Debt
$42.22M
Equity
$40.2M
Working capital
-$28.78M
Debt to equity
1.05
Current ratio
0.37
Quick ratio
0.23
Net debt/EBITDA
0.92
Margins
Efficiency
Dividend
EBITDA margin
31.1%
Gross margin
61.9%
Net margin
20%
Operating margin
26.9%
Return on assets
24.3%
Return on equity
63.6%
Return on invested capital
83%
Return on capital employed
54%
Return on sales
27.1%
Dividend yield
6.92%
DPS
$1.48
Payout ratio
122.3%
NRC stock price
How has the National Research stock price performed over time
Intraday
-1.11%
1 week
-3.86%
1 month
1.04%
1 year
-52.81%
YTD
-45.9%
QTD
-6.75%
Financial performance
How have National Research's revenue and profit performed over time
Revenue
$146.28M
Gross profit
$90.58M
Operating income
$39.29M
Net income
$29.27M
Gross margin
61.9%
Net margin
20%
NRC's operating income is down by 6% YoY
National Research's operating margin has decreased by 4.3% YoY
NRC's net income is down by 3.6% QoQ
National Research's net margin has decreased by 2.9% QoQ
Growth
What is National Research's growth rate over time
Valuation
What is National Research stock price valuation
P/E
17.69
P/B
12.71
P/S
3.49
EV/EBIT
13.95
EV/EBITDA
12.13
EV/Sales
3.78
The stock's price to earnings (P/E) is 46% less than its 5-year quarterly average of 32.8 and 41% less than its last 4 quarters average of 30.0
The EPS has declined by 3.2% since the previous quarter
National Research's equity has decreased by 48% YoY but it has increased by 9% QoQ
NRC's price to book (P/B) is 39% less than its 5-year quarterly average of 20.9 and 35% less than its last 4 quarters average of 19.5
The P/S is 56% lower than the 5-year quarterly average of 7.9 and 42% lower than the last 4 quarters average of 6.0
Efficiency
How efficient is National Research business performance
NRC's return on equity has surged by 59% year-on-year and by 16% since the previous quarter
NRC's return on invested capital is down by 36% year-on-year and by 11% since the previous quarter
The return on assets has increased by 11% year-on-year
Dividends
What is NRC's dividend history
DPS
$1.48
Dividend yield
6.92%
Payout ratio
122.3%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did National Research financials performed over time
NRC's total assets is 51% greater than its total liabilities
The quick ratio has dropped by 77% year-on-year and by 12% since the previous quarter
NRC's current ratio has shrunk by 69% YoY and by 10% QoQ
National Research's debt is 5% higher than its equity
National Research's debt has surged by 111% YoY
National Research's equity has decreased by 48% YoY but it has increased by 9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.